Florian van Bömmel

A global scientific strategy to cure hepatitis B

Peter Revill, Francis V. Chisari, Joan M. Block et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 495 citations · Full text

Pharmacy, Biomedical Sciences, Infectious Diseases +14

Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus Infection

Florian van Bömmel, Thomas Wünsche, Stefan Mauss et al. · Hepatology · 2004 · 390 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer et al. · Hepatology · 2009 · 330 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos et al. · Hepatology · 2017 · 292 citations

Medicine, Oncology, Pharmacotherapy +15

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy

Florian van Bömmel, Bernhard Zöllner, Christoph Sarrazin et al. · Hepatology · 2006 · 289 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17